0.7929 | +0.0129 / +1.65%Today’s Change | 0.72 Today|||52-Week Range 1.64 | -9.91% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $58.3M |
Company Description
NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients suffering from life-threatening viral infections. It intends to manufacture Injectable and Oral FluCide, HIVCide, Nanoviricide Eye Drops, HerpeCide, DengueCide, RabiCide as well as other drugs for pre-clinical animal studies and human clinical studies. The company was founded by Anil R. Diwan on July 25, 2000 and is headquartered in Shelton, CT.
Employees

Shareholders
Individual stakeholders | 9.62% |
Other institutional | 2.86% |
Mutual fund holders | 2.42% |
Top Executives
Anil R. Diwan | Chairman, President & Chief Executive Officer |
Meeta R. Vyas | Chief Financial & Accounting Officer |
Randall W. Barton | Chief Scientific Officer |
Jayant Tatake | Vice President-Research & Development |